Prostate cancer cells with BRCA2 deficiency may tolerate the genomic and chromosomal instability caused by BRCA2 deficiency by silencing SAC activation in the process of cancer occurrence and progression. The gene discussed is BRCA2; the disease is Familial prostate cancer.